Blockchain Registration Transaction Record

Quantumzyme Expands AI Enzyme Platform for Green Pharma Manufacturing

Quantumzyme expands AI enzyme platform for green pharmaceutical manufacturing, targeting high-volume APIs to reduce waste and carbon emissions while improving supply chain sustainability.

This development matters because traditional pharmaceutical manufacturing generates massive environmental waste and relies heavily on toxic solvents and energy-intensive processes. As the global API market approaches $300 billion, the shift toward sustainable biocatalysis could significantly reduce industrial pollution, lower carbon emissions, and create more resilient domestic supply chains. For consumers, this means potentially safer, more environmentally friendly medications while addressing critical sustainability challenges in an industry that has historically been a major polluter.